Key result
Higher remnant cholesterol linked to ~2.8-fold higher ischemic heart disease risk independent of HDL.
Why the study?
Is elevated nonfasting remnant cholesterol a causal risk factor for ischemic heart disease independent of reduced HDL cholesterol?
Observational (n=73,513)
Mendelian randomization
Is elevated nonfasting remnant cholesterol a causal risk factor for ischemic heart disease independent of reduced HDL cholesterol?
Answers are grounded in this paper and cite their sources.
Elevated nonfasting remnant cholesterol is a causal risk factor for ischemic heart disease, independent of reduced HDL cholesterol.
OBJECTIVES The aim of this study was to test the hypothesis that elevated nonfasting remnant cholesterol is a causal risk factor for ischemic heart disease independent of reduced high-density lipoprotein (HDL) cholesterol. BACKGROUND Elevated remnant cholesterol is associated with elevated levels of triglyceride-rich lipoproteins and with reduced HDL cholesterol, and all are associated with ischemic heart disease. METHODS A total of 73,513 subjects from Copenhagen were genotyped, of whom 11,984 had ischemic heart disease diagnosed between 1976 and 2010. Fifteen genetic variants were selected, affecting: 1) nonfasting remnant cholesterol alone; 2) nonfasting remnant cholesterol and HDL cholesterol combined; 3) HDL cholesterol alone; or 4) low-density lipoprotein (LDL) cholesterol alone as a positive control. The variants were used in a Mendelian randomization design. RESULTS The causal odds ratio for a 1 mmol/l (39 mg/dl) genetic increase of nonfasting remnant cholesterol was 2.8 (95% confidence interval [CI]: 1.9 to 4.2), with a corresponding observational hazard ratio of 1.4 (95% CI: 1.3 to 1.5). For the ratio of nonfasting remnant cholesterol to HDL cholesterol, corresponding values were 2.9 (95% CI: 1.9 to 4.6) causal and 1.2 (95% CI 1.2 to 1.3) observational for a 1-U increase. However, for HDL cholesterol, corresponding values were 0.7 (95% CI: 0.4 to 1.4) causal and 1.6 (95% CI: 1.4 to 1.7) observational for a 1 mmol/l (39 mg/dl) decrease. Finally, for LDL cholesterol, corresponding values were 1.5 (95% CI: 1.3 to 1.6) causal and 1.1 (95% CI: 1.1 to 1.2) observational for a 1 mmol/l (39 mg/dl) increase. CONCLUSIONS A nonfasting remnant cholesterol increase of 1 mmol/l (39 mg/dl) is associated with a 2.8-fold causal risk for ischemic heart disease, independent of reduced HDL cholesterol. This implies that elevated cholesterol content of triglyceride-rich lipoprotein particles causes ischemic heart disease. However, because pleiotropic effects of the genetic variants studied cannot be totally excluded, these findings need to be confirmed using additional genetic variants and/or randomized intervention trials.
No takes yet. Share an insight, caveat, or question.
Varbo et al. (2012) conducted an observational in Ischemic heart disease (n=73,513). Elevated nonfasting remnant cholesterol vs. Lower nonfasting remnant cholesterol was evaluated on Ischemic heart disease (OR 2.8, 95% CI 1.9 to 4.2). A 1 mmol/l genetic increase in nonfasting remnant cholesterol was associated with a 2.8-fold causal risk for ischemic heart disease, independent of reduced HDL.
Synapse has enriched 10 related papers. Consider them for comparative context: